Gunzburg: vaccinated against COVID-19 in addition to a nasal vaccine will not be a carrier 
Creator of Sputnik V “, Director of the National Research Center for Epidemiology of microbiology named after Gamaleya Alexander Gintsburg spoke about the advantages of a nasal vaccine against coronavirus, reports RIA Novosti.
According to him, if vaccinated against COVID-19 are vaccinated with an additional nasal drug, they will cease to be carriers of infection. “In such people, most likely, who will be internally vaccinated, sterile immunity will be created,” said Gunzburg.
He explained that when using a conventional vaccine there is no guarantee that the vaccinated coronavirus will not settle on the tonsils and in the nasopharynx.
In October, the Ministry of Health of Russia allowed the Gamaleya Center to conduct the second phase of clinical trials of a coronavirus vaccine in the form of a nasal spray. The director of the institution, Alexander Gintsburg, said that this vaccine would not cancel the need for routine vaccinations. The nasal drug complements it, creating another barrier to the coronavirus.